Universal Biosensors Inc (UBI)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Universal Biosensors Inc (UBI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011972
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Universal Biosensors Inc (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. UBI’s major focus areas include coagulation testing, blood glucose testing and other electromechanical cell based tests. Its in-vitro diagnostic test devices are based on electrochemical cell technology platform. The company manages its research and development, and manufacturing operations through its subsidiary, Universal Biosensors Pty Ltd (UBS) in Melbourne. UBI is headquartered in Melbourne, Victoria, Australia.

Universal Biosensors Inc (UBI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Universal Biosensors Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Universal Biosensors Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Universal Biosensors Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Universal Biosensors Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Universal Biosensors Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Universal Biosensors Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Universal Biosensors to Acquire Hemostasis Reference Lab Business from LifeLabs 10
Partnerships 11
Universal Biosensors Enters Into Licensing Agreement With SpeeDx 11
Siemens Healthcare Diagnostics Amends its Co-Development Agreement with Universal Biosensors 12
Equity Offering 13
Universal Biosensors Completes Private Placement Of Shares For US$12 Million 13
Universal Biosensors Inc – Key Competitors 14
Universal Biosensors Inc – Key Employees 15
Universal Biosensors Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Oct 24, 2017: Universal Biosensors releases Q3 2017 results – continued revenue growth strengthens net cash position 17
Apr 27, 2017: Universal Biosensors reports strong growth in revenue and profit in Q1 2017 18
Feb 27, 2017: Universal Biosensors announces FY2016 unaudited results showing strong revenue growth and positive operating cash flow 19
Aug 20, 2016: Universal Biosensors reports growing revenues in 3Q16 with positive cash flow 20
Jul 21, 2016: Universal Biosensors: Revenue up 41% on pcp as Quarterly Service Fees continue to grow 21
Jul 21, 2016: Universal Biosensors Announced its financial results for the first half of 2016 22
Apr 21, 2016: Universal Biosensors Reports Q1 2016 Results 23
Corporate Communications 24
Aug 07, 2017: Rick Legleiter Appointed Chief Executive Officer, Chairman Succession and Board Renewal Process 24
Jun 30, 2016: UBI appoints Craig Coleman as Non-Executive Director 26
Mar 02, 2016: Universal Biosensors Appoints David Hoey as Non-Executive Director 27
Feb 19, 2016: Universal Biosensors Announces Retirement of CEO Paul Wright 28
Other Significant Developments 29
Apr 01, 2016: Universal Biosensors – Update 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Universal Biosensors Inc, Medical Equipment, Key Facts, 2016 2
Universal Biosensors Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Universal Biosensors Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Universal Biosensors Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Universal Biosensors Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Universal Biosensors Inc, Deals By Market, 2011 to YTD 2017 8
Universal Biosensors Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Universal Biosensors to Acquire Hemostasis Reference Lab Business from LifeLabs 10
Universal Biosensors Enters Into Licensing Agreement With SpeeDx 11
Siemens Healthcare Diagnostics Amends its Co-Development Agreement with Universal Biosensors 12
Universal Biosensors Completes Private Placement Of Shares For US$12 Million 13
Universal Biosensors Inc, Key Competitors 14
Universal Biosensors Inc, Key Employees 15
Universal Biosensors Inc, Subsidiaries 16

★海外企業調査レポート[Universal Biosensors Inc (UBI)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • InFlectis BioScience:製薬・医療:M&Aディール及び事業提携情報
    Summary InFlectis BioScience (InFlectis) is a drug discovery company that identifies and develops small molecule drugs that target the unfolded protein response to treat misfolding protein disorders such as age-related and neurodegenerative diseases. The company’s pipeline products include IFB-088, …
  • Oriental Hotels Ltd
    Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • MakeMyTrip Limited:企業の戦略・SWOT・財務分析
    MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report Summary MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Lund University:製薬・医療:M&Aディール及び事業提携情報
    Summary Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The universi …
  • Birks Group Inc (BGI):企業の財務・戦略的SWOT分析
    Birks Group Inc (BGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bsquare Corporation (BSQR):企業の財務・戦略的SWOT分析
    Bsquare Corporation (BSQR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Teledyne Technologies Incorporated (TDY):石油・ガス:M&Aディール及び事業提携情報
    Summary Teledyne Technologies Incorporated (Teledyne) is a provider of enabling technologies for industrial growth markets. The company’s product portfolio comprises digital imaging sensors, cameras and systems, infrared and X-ray spectra, monitoring and control instrumentation. It also offers elect …
  • JSW Steel Ltd:企業の戦略・SWOT・財務情報
    JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report Summary JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Aevis Victoria SA (AEVS):製薬・医療:M&Aディール及び事業提携情報
    Summary Aevis Victoria SA (Aevis Victoria), a subsidiary of Medical Research, Services & Investments SA, is a diversified company that invests in healthcare, hospitality, telemedicine, life sciences and lifestyle. It owns and operates outpatient surgical centres, hospitals, medical network, and cent …
  • Axis Bank Limited:企業の戦略・SWOT・財務情報
    Axis Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Axis Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • DIC Corp (4631):企業の財務・戦略的SWOT分析
    DIC Corp (4631) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • A.P. Eagers Limited:戦略・SWOT・企業財務分析
    A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report Summary A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sonoco Products Co (SON):企業の財務・戦略的SWOT分析
    Sonoco Products Co (SON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Thomson Reuters Corporation:企業のM&A・事業提携・投資動向
    Thomson Reuters Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Thomson Reuters Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Correvio International Sarl-製薬・医療分野:企業M&A・提携分析
    Summary Correvio International Sarl (Correvio International), formerly Iroko Cardio International Sarl, a subsidiary of Cardiome Pharma Corp, healthcare solution provider. The company develops an integrated pharmaceutical platform that offers production, distribution, regulatory, medical, health eco …
  • Aker Solutions ASA:企業のM&A・事業提携・投資動向
    Aker Solutions ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aker Solutions ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Mattel, Inc.:企業の戦略・SWOT・財務情報
    Mattel, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mattel, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • WGL Holdings Inc (WGL):企業の財務・戦略的SWOT分析
    WGL Holdings Inc (WGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Sodra Skogsagarna ekonomisk forening:企業の戦略的SWOT分析
    Sodra Skogsagarna ekonomisk forening - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • 3P Biopharmaceuticals SL-製薬・医療分野:企業M&A・提携分析
    Summary 3P Biopharmaceuticals SL (3P), a subsidiary of Infarco SA is a biotechnology company that offers biological and cell therapy products. The company offers biologic services such as cell-banks, process development, GMP manufacturing and analytical QC services. Its cell therapy services compris …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆